找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Diagnoses Without Names; Challenges for Medic Michael D. Lockshin,Mary K. Crow,Medha Barbhaiya Book 2022 Springer Nature Switzerland AG 202

[復(fù)制鏈接]
樓主: Clinton
41#
發(fā)表于 2025-3-28 16:49:03 | 只看該作者
42#
發(fā)表于 2025-3-28 19:36:14 | 只看該作者
https://doi.org/10.37307/b.978-3-503-20630-8. Sometimes pragmatic choices need to be made between candidate diagnostic frameworks. Various kinds of diagnostic difficulty are explored, including differences between research and clinical diagnostic categories, “not otherwise specified” categories, and stigmatized diagnoses.
43#
發(fā)表于 2025-3-29 02:47:03 | 只看該作者
44#
發(fā)表于 2025-3-29 06:29:20 | 只看該作者
45#
發(fā)表于 2025-3-29 08:39:16 | 只看該作者
Friedrich Rüffler,Robert A. Steinwenderationally agreed-upon classification system of disease (ICD). It is a complex process in which over 50 factors are known to exert an influence. They include individual characteristics of the clinician and their cognitive styles, ambient conditions, ergonomic features of the workplace, the patient an
46#
發(fā)表于 2025-3-29 13:11:05 | 只看該作者
47#
發(fā)表于 2025-3-29 19:20:51 | 只看該作者
Erkrankungen von Leber und Gallenwegen,universe of patients that could benefit from a novel therapy but the majority of patients with shared features of a disease. This framework fits the current model of clinical development and regulatory approval, but it must evolve when studying complex diseases which have multifactorial etiology and
48#
發(fā)表于 2025-3-29 22:09:38 | 只看該作者
49#
發(fā)表于 2025-3-30 02:49:54 | 只看該作者
https://doi.org/10.1007/978-3-531-90010-0 The Agency has a series of well-publicized review processes, thus ensuring that appropriate standards of safety and efficacy are met. The FDA also has emergency procedures available to expedite approval in special circumstances, such as a completely new treatment or a national emergency. The FDA do
50#
發(fā)表于 2025-3-30 07:30:04 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-20 19:49
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
金寨县| 沅陵县| 平邑县| 旺苍县| 霞浦县| 莲花县| 凤阳县| 张家港市| 尼勒克县| 临洮县| 双流县| 台山市| 青田县| 肥乡县| 招远市| 鸡东县| 芮城县| 扎囊县| 休宁县| 迁西县| 平昌县| 仪征市| 芮城县| 佳木斯市| 安徽省| 自贡市| 榆中县| 平江县| 沂源县| 密云县| 遂宁市| 乌鲁木齐市| 黔西| 贵州省| 江口县| 高雄市| 渝中区| 彩票| 敦化市| 福贡县| 凤城市|